Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

74.8K
Overview
74.8K
Tissue Transplantation01:24

Tissue Transplantation

551
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
551
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

538
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
538
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseases.

NPJ precision oncology·2026
Same author

NK cell dysfunction and interferon-γ production underlie autoinflammation in mevalonate kinase deficiency.

Immunity·2026
Same author

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party.

Bone marrow transplantation·2025
Same author

Autologous haematopoietic stem cell transplantation in non-MS neuroimmunological diseases.

Multiple sclerosis and related disorders·2025
Same author

A call to standardize the nomenclature of human fetal membrane at the feto-maternal interface.

Placenta·2025
Same author

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Brain : a journal of neurology·2025
Same journal

Factors Associated With the Rising Trend in Self-Reported Cognitive Disability Among U.S. Adults Aged 18-39 From 2013-2024.

Annals of clinical and translational neurology·2026
Same journal

Bi- and Mono-Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy.

Annals of clinical and translational neurology·2026
Same journal

Characterizing Cutaneous α-Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes.

Annals of clinical and translational neurology·2026
Same journal

Effects of Add-On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial.

Annals of clinical and translational neurology·2026
Same journal

Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same journal

A 57-Year-Old Male With Behavioral Variant Frontotemporal Dementia and MATR3 and NOS3 Mutations.

Annals of clinical and translational neurology·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K

Sustained immunotolerance in multiple sclerosis after stem cell transplant.

Malini Visweswaran1,2, Kevin Hendrawan1,2, Jennifer C Massey1,2,3,4

  • 1Blood, Stem Cells and Cancer Research Laboratory, St Vincent's Centre for Applied Medical Research, Darlinghurst, Sydney, New South Wales, Australia.

Annals of Clinical and Translational Neurology
|February 2, 2022
PubMed
Summary
This summary is machine-generated.

Autologous haematopoietic stem cell transplantation (AHSCT) recalibrates the immune system in multiple sclerosis (MS) patients. This study details immune cell changes up to 36 months post-transplant, revealing reduced inflammation and enhanced regulation.

More Related Videos

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.9K

Related Experiment Videos

Last Updated: Oct 4, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.9K

Area of Science:

  • Immunology
  • Neuroscience
  • Transplantation Medicine

Background:

  • Multiple sclerosis (MS) is a CNS inflammatory disease with demyelination and axonal degeneration.
  • Autologous haematopoietic stem cell transplantation (AHSCT) shows potential for sustained MS remission.
  • Mechanisms of durable AHSCT responses in MS require further investigation.

Purpose of the Study:

  • To characterize long-term immune reconstitution following AHSCT in MS patients.
  • To analyze immune cell changes at 24 and 36 months post-transplant.
  • To correlate immune dynamics with clinical outcomes.

Main Methods:

  • High-dimensional immunophenotyping of peripheral blood mononuclear cells.
  • Utilized two custom-designed 18-color flow cytometry panels.
  • Analyzed samples from 22 MS patients at 24 and 36 months post-AHSCT.

Main Results:

  • Decreased frequencies of pro-inflammatory cells (Th17, T-conv) and increased regulatory cells (NK cells, CD8+ T cells) observed.
  • Sustained increase in naïve B-cells with depletion of memory B-cells and plasmablasts.
  • Responder patients showed reduced pro-inflammatory subsets and increased regulatory T-cells.

Conclusions:

  • AHSCT induces significant immune system recalibration in MS patients up to 36 months.
  • Changes include reduced pro-inflammatory immune cells and enhanced immunoregulatory components.
  • Immune dynamics post-AHSCT correlate with clinical response in MS patients.